BPC-157 vs. TB-500: The 2026 Recovery Peptide Comparison
FDA update — July 2026: An FDA advisory panel voted July 23–24 to recommend adding BPC-157 and TB-500 to the federal 503A compounding list — the strongest regulatory signal yet for the compound, though final FDA rulemaking is still ahead. Read our full vote coverage. BPC-157 and TB-500 is available today with a physician’s prescription […]
Read More